Filing Details
- Accession Number:
- 0001179110-15-007643
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-05-12 17:28:52
- Reporting Period:
- 2015-05-08
- Filing Date:
- 2015-05-12
- Accepted Time:
- 2015-05-12 17:28:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 815094 | Abiomed Inc | ABMD | Surgical & Medical Instruments & Apparatus (3841) | 042743260 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1286370 | R Michael Minogue | C/O Abiomed, Inc., 22 Cherry Hill Drive Danvers MA 01923 | President, Ceo, Chairman | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock $.01 Par Value | Acquisiton | 2015-05-08 | 42,202 | $11.27 | 374,674 | No | 4 | M | Direct | |
| Common Stock $.01 Par Value | Acquisiton | 2015-05-08 | 15,000 | $13.80 | 389,674 | No | 4 | M | Direct | |
| Common Stock $.01 Par Value | Disposition | 2015-05-08 | 10,805 | $64.16 | 378,869 | No | 4 | S | Direct | |
| Common Stock $.01 Par Value | Disposition | 2015-05-08 | 12,129 | $65.13 | 366,740 | No | 4 | S | Direct | |
| Common Stock $.01 Par Value | Disposition | 2015-05-08 | 6,372 | $66.33 | 360,368 | No | 4 | S | Direct | |
| Common Stock $.01 Par Value | Disposition | 2015-05-08 | 16,266 | $67.33 | 344,102 | No | 4 | S | Direct | |
| Common Stock $.01 Par Value | Disposition | 2015-05-08 | 9,213 | $67.88 | 334,889 | No | 4 | S | Direct | |
| Common Stock $.01 Par Value | Disposition | 2015-05-08 | 2,175 | $69.03 | 332,714 | No | 4 | S | Direct | |
| Common Stock $.01 Par Value | Disposition | 2015-05-08 | 242 | $69.81 | 332,472 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2015-05-08 | 42,202 | $0.00 | 42,202 | $11.27 |
| Common Stock | Stock Option (right to buy) | Disposition | 2015-05-08 | 15,000 | $0.00 | 15,000 | $13.80 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2008-05-30 | 2017-05-30 | No | 4 | M | Direct |
| 28,333 | 2009-05-23 | 2018-05-23 | No | 4 | M | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | $13.57 | 2007-06-01 | 2016-06-01 | 0 | 82,000 | Direct |
| Common Stock | Stock Option (right to buy) | $18.63 | 2009-06-15 | 2018-08-13 | 0 | 76,875 | Direct |
| Common Stock | Stock Option (right to buy) | $5.86 | 2010-05-28 | 2019-05-28 | 0 | 146,800 | Direct |
| Common Stock | Stock Option (right to buy) | $5.86 | 2010-05-28 | 2019-05-28 | 0 | 56,700 | Direct |
| Common Stock | Stock Option (right to buy) | $10.03 | 2011-06-03 | 2020-06-03 | 0 | 105,000 | Direct |
| Common Stock | Stock Option (Right to Buy) | $22.44 | 2013-05-22 | 2022-05-22 | 0 | 50,000 | Direct |
| Common Stock | Stock Option (Right to Buy) | $23.15 | 2014-05-14 | 2024-05-14 | 0 | 21,250 | Direct |
| Common Stock | Stock Option (right to buy) | $21.55 | 2015-05-14 | 2024-05-14 | 0 | 85,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2016-06-01 | 0 | 82,000 | Direct |
| 2018-08-13 | 0 | 76,875 | Direct |
| 2019-05-28 | 0 | 146,800 | Direct |
| 2019-05-28 | 0 | 56,700 | Direct |
| 2020-06-03 | 0 | 105,000 | Direct |
| 2022-05-22 | 0 | 50,000 | Direct |
| 2024-05-14 | 0 | 21,250 | Direct |
| 2024-05-14 | 0 | 85,000 | Direct |
Footnotes
- Grant to reporting person of option to buy shares of Common Stock under the ABIOMED, Inc. 2000 Stock Incentive Plan.
- These options become exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6.
- Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
- These options become exercisable based on the achievement of certain performance milestones.
- Sale of common stock pursuant to reporting owner's 10b5-1 plan.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $63.6200 and $64.6100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $64.6200 and $65.6100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $65.6750 and $66.6500. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $66.7000 and $67.6900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $67.7000 and $68.6600. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $68.7000 and $69.6900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $69.7000 and $69.9600. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Billionaire Hedge Funds
